Skip to main content
Log in

Identification and characterization of novel and rare susceptible variants in Indian amyotrophic lateral sclerosis patients

  • Original Article
  • Published:
neurogenetics Aims and scope Submit manuscript

Abstract

Rare missense variants play a crucial role in amyotrophic lateral sclerosis (ALS) pathophysiology. We report rare/novel missense variants from 154 Indian ALS patients, identified through targeted sequencing of 25 ALS-associated genes. As pathogenic variants could explain only a small percentage of ALS pathophysiology in our cohort, we investigated the frequency of tolerated and benign novel/rare variants, which could be potentially ALS susceptible. These variants were identified in 5.36% (8/149) of sporadic ALS (sALS) cases; with one novel variant each in ERBB4, SETX, DCTN1, and MATR3; four rare variants, one each in PON2 and ANG and two different rare variants in SETX. Identified variants were either absent or present at extremely rare frequencies (MAF < 0.01) in large population databases and were absent in 50 healthy controls sequenced through Sanger method. Furthermore, an oligogenic basis of ALS was observed in three sALS, with co-occurrence of intermediate-length repeat expansions in ATXN2 and a rare/novel variant in DCTN1 and SETX genes. Additionally, molecular dynamics and biochemical functional analysis of an angiogenin variant (R21G) identified from our cohort demonstrated loss of ribonucleolytic and nuclear translocation activities. Our findings suggest that rare variants could be potentially pathogenic and functional studies are warranted to decisively establish the pathogenic mechanisms associated with them.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Renton AE, Chiò A, Traynor BJ (2014) State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci

  2. Al-Chalabi A, Hardiman O (2013) The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. https://doi.org/10.1038/nrneurol.2013.203

  3. Cady J, Allred P, Bali T et al (2015) Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes. Ann Neurol. https://doi.org/10.1002/ana.24306

  4. Pang SYY, Hsu JS, Teo KC et al (2017) Burden of rare variants in ALS genes influences survival in familial and sporadic ALS. Neurobiol Aging. https://doi.org/10.1016/j.neurobiolaging.2017.06.007

  5. Krüger S, Battke F, Sprecher A et al (2016) Rare variants in neurodegeneration associated genes revealed by targeted panel sequencing in a German ALS cohort. Front Mol Neurosci. https://doi.org/10.3389/fnmol.2016.00092

  6. Marangi G, Traynor BJ (2015) Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges. Brain Res

  7. Wu D, Yu W, Kishikawa H et al (2007) Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Ann Neurol. https://doi.org/10.1002/ana.21221

  8. Padhi AK, Vasaikar SV, Jayaram B, Gomes J (2014) ANGDelMut—a web-based tool for predicting and analyzing functional loss mechanisms of amyotrophic lateral sclerosis-associated angiogenin mutations. F1000Research. https://doi.org/10.12688/f1000research.2-227.v3

  9. Thiyagarajan N, Ferguson R, Subramanian V, Acharya KR (2012) Structural and molecular insights into the mechanism of action of human angiogenin-ALS variants in neurons. Nat Commun. https://doi.org/10.1038/ncomms2126

  10. Boehringer A, Garcia-Mansfield K, Singh G et al (2017) ALS associated mutations in Matrin 3 alter protein-protein interactions and impede mRNA nuclear export. Sci Rep. https://doi.org/10.1038/s41598-017-14924-6

  11. Marangi G, Lattante S, Doronzio PN et al (2017) Matrin 3 variants are frequent in Italian ALS patients. Neurobiol Aging. https://doi.org/10.1016/j.neurobiolaging.2016.09.023

  12. Padhi AK, Narain P, Dave U et al (2019) Insights into the role of ribonuclease 4 polymorphisms in amyotrophic lateral sclerosis. J Biomol Struct Dyn. https://doi.org/10.1080/07391102.2017.1419147

  13. de Majo M, Topp SD, Smith BN et al (2018) ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function. Neurobiol Aging. https://doi.org/10.1016/j.neurobiolaging.2018.06.015

  14. Higelin J, Catanese A, Semelink-Sedlacek LL et al (2018) NEK1 loss-of-function mutation induces DNA damage accumulation in ALS patient-derived motoneurons. Stem Cell Res. https://doi.org/10.1016/j.scr.2018.06.005

  15. Padhi AK, Hazra S (2019) Insights into the role of d-amino acid oxidase mutations in amyotrophic lateral sclerosis. J Cell Biochem. https://doi.org/10.1002/jcb.27529

  16. Narain P, Gomes J, Bhatia R et al (2017) C9orf72 hexanucleotide repeat expansions and Ataxin 2 intermediate length repeat expansions in Indian patients with amyotrophic lateral sclerosis. Neurobiol Aging. https://doi.org/10.1016/j.neurobiolaging.2017.04.011

  17. Narain P, Pandey A, Gupta S et al (2018) Targeted next-generation sequencing reveals novel and rare variants in Indian patients with amyotrophic lateral sclerosis. Neurobiol Aging. https://doi.org/10.1016/j.neurobiolaging.2018.05.012

  18. Ng PC, Henikoff S (2003) SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res

  19. Adzhubei IA, Schmidt S, Peshkin L et al (2010) A method and server for predicting damaging missense mutations. Nat Methods. https://doi.org/10.1038/nmeth0410-248

  20. Lek M, Karczewski KJ, Minikel EV et al (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature. https://doi.org/10.1038/nature19057

  21. Padhi AK, Kumar H, Vasaikar SV et al (2012) Mechanisms of loss of functions of human angiogenin variants implicated in amyotrophic lateral sclerosis. PLoS One. https://doi.org/10.1371/journal.pone.0032479

  22. Padhi AK, Banerjee K, Gomes J, Banerjee M (2014) Computational and functional characterization of angiogenin mutations, and correlation with amyotrophic lateral sclerosis. PLoS One. https://doi.org/10.1371/journal.pone.0111963

  23. Al-Chalabi A, Van Den Berg LH, Veldink J (2017) Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nat Rev Neurol

  24. Sproviero W, Shatunov A, Stahl D et al (2017) ATXN2 trinucleotide repeat length correlates with risk of ALS. Neurobiol Aging. https://doi.org/10.1016/j.neurobiolaging.2016.11.010

  25. Abel O, Powell JF, Andersen PM, Al-Chalabi A (2012) ALSoD: a user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics. Hum Mutat. https://doi.org/10.1002/humu.22157

  26. Lin KP, Tsai PC, Liao YC et al (2015) Mutational analysis of MATR3 in Taiwanese patients with amyotrophic lateral sclerosis. Neurobiol Aging. https://doi.org/10.1016/j.neurobiolaging.2015.02.008

  27. Xu L, Li J, Tang L et al (2015) MATR3 mutation analysis in a Chinese cohort with sporadic amyotrophic lateral sclerosis. Neurobiol Aging. https://doi.org/10.1016/j.neurobiolaging.2015.11.023

  28. Leblond CS, Gan-Or Z, Spiegelman D et al (2016) Replication study of MATR3 in familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging. https://doi.org/10.1016/j.neurobiolaging.2015.09.013

  29. Brown RH, Al-Chalabi A (2017) Amyotrophic lateral sclerosis. Prog Med Chem. https://doi.org/10.1016/bs.pmch.2018.12.001

  30. Couthouis J, Raphael AR, Daneshjou R, Gitler AD (2014) Targeted exon capture and sequencing in sporadic amyotrophic lateral sclerosis. PLoS Genet. https://doi.org/10.1371/journal.pgen.1004704

  31. Kenna KP, McLaughlin RL, Byrne S et al (2013) Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing. J Med Genet. https://doi.org/10.1136/jmedgenet-2013-101795

  32. Maruyama H, Morino H, Ito H et al (2010) Mutations of optineurin in amyotrophic lateral sclerosis. Nature. https://doi.org/10.1038/nature08971

  33. Nakamura R, Sone J, Atsuta N et al (2016) Next-generation sequencing of 28 ALS-related genes in a Japanese ALS cohort. Neurobiol Aging. https://doi.org/10.1016/j.neurobiolaging.2015.11.030

  34. Takahashi Y, Fukuda Y, Yoshimura J et al (2013) Erbb4 mutations that disrupt the neuregulin-erbb4 pathway cause amyotrophic lateral sclerosis type 19. Am J Hum Genet. https://doi.org/10.1016/j.ajhg.2013.09.008

  35. Zhang G, Li W, Li Z et al (2013) Association between paraoxonase gene and stroke in the Han Chinese population. BMC Med Genet. https://doi.org/10.1186/1471-2350-14-16

  36. Valdmanis PN, Kabashi E, Dyck A et al (2008) Association of paraoxonase gene cluster polymorphisms with ALS in France, Quebec, and Sweden. Neurology. https://doi.org/10.1212/01.wnl.0000324997.21272.0c

  37. Saeed M, Siddique N, Hung WY et al (2006) Paraoxonase cluster polymorphisms are associated with sporadic ALS. Neurology. https://doi.org/10.1212/01.wnl.0000227187.52002.88

  38. Slowik A, Tomik B, Wolkow PP et al (2006) Paraoxonase gene polymorphisms and sporadic ALS. Neurology. https://doi.org/10.1212/01.wnl.0000219565.32247.11

  39. Chen Y-Z, Bennett CL, Huynh HM et al (2004) DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet. https://doi.org/10.1086/421054

  40. Hirano M, Quinzii CM, Mitsumoto H et al (2011) Senataxin mutations and amyotrophic lateral sclerosis. Amyotroph Lateral Scler. https://doi.org/10.3109/17482968.2010.545952

  41. Tripolszki K, Danis J, Padhi AK et al (2019) Angiogenin mutations in Hungarian patients with amyotrophic lateral sclerosis: clinical, genetic, computational, and functional analyses. Brain Behav. https://doi.org/10.1002/brb3.1293

Download references

Acknowledgments

Helpful suggestions from Prof B. Jayaram (IIT Delhi) are gratefully acknowledged.

Funding

The authors gratefully acknowledge the funding received from the Kusuma Trust UK and the financial and infrastructure support of the Indian Institute of Technology, Delhi for carrying out this research. DM, PN, and UD were supported by Research Fellowship from IIT Delhi, India.

Author information

Authors and Affiliations

Authors

Contributions

PN, AKP, VP, and JG conceived and designed the experiments. PN performed the experiments. AKP performed molecular dynamics simulations and analyses. PN, UD, and DM handled protein purification and assays. PN, AKP, UD, DM, VP, and JG analyzed the data. RB handled patient recruitment and clinical evaluation. PN, AKP, RB, VP, and JG contributed to the writing of the manuscript.

Corresponding author

Correspondence to James Gomes.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(PDF 1.99 MB)

ESM 2

(DOCX 15 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Narain, P., Padhi, A.K., Dave, U. et al. Identification and characterization of novel and rare susceptible variants in Indian amyotrophic lateral sclerosis patients. Neurogenetics 20, 197–208 (2019). https://doi.org/10.1007/s10048-019-00584-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10048-019-00584-3

Keywords

Navigation